These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24382375)

  • 1. Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected].
    Hillman JK; Johnson LN; Limaye M; Feldman RA; Sammel M; Dokras A
    Fertil Steril; 2014 Feb; 101(2):530-5. PubMed ID: 24382375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Syndrome: A Longitudinal Study.
    Lee I; Vresilovic J; Irfan M; Gallop R; Dokras A
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1558-e1567. PubMed ID: 34928388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does polycystic ovary syndrome increase the disparity in metabolic syndrome and cardiovascular-related health for African-American women?
    Coney P; Ladson G; Sweet S; Legro RS
    Semin Reprod Med; 2008 Jan; 26(1):35-8. PubMed ID: 18181080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
    Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study.
    Ladson G; Dodson WC; Sweet SD; Archibong AE; Kunselman AR; Demers LM; Williams NI; Coney P; Legro RS
    Fertil Steril; 2011 Jul; 96(1):224-229.e2. PubMed ID: 21723443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Kazemi M; Kim JY; Parry SA; Azziz R; Lujan ME
    Am J Obstet Gynecol; 2021 May; 224(5):428-444.e8. PubMed ID: 33316275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts.
    Koval KW; Setji TL; Reyes E; Brown AJ
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E49-53. PubMed ID: 20534766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).
    Kumar A; Woods KS; Bartolucci AA; Azziz R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):644-9. PubMed ID: 15943823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006.
    Johnson WD; Kroon JJ; Greenway FL; Bouchard C; Ryan D; Katzmarzyk PT
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):371-7. PubMed ID: 19349567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome.
    Gambineri A; Repaci A; Patton L; Grassi I; Pocognoli P; Cognigni GE; Pasqui F; Pagotto U; Pasquali R
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):797-804. PubMed ID: 19359152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
    Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
    Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome.
    Vipin VP; Dabadghao P; Shukla M; Kapoor A; Raghuvanshi AS; Ramesh V
    Fertil Steril; 2016 May; 105(5):1338-1344.e3. PubMed ID: 26852421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome.
    Marchesan LB; Spritzer PM
    Fertil Steril; 2019 Mar; 111(3):579-587.e1. PubMed ID: 30827526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women's study.
    Wang ET; Ku IA; Shah SJ; Daviglus ML; Schreiner PJ; Konety SH; Williams OD; Siscovick D; Bibbins-Domingo K
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4656-62. PubMed ID: 23012389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype.
    Engmann L; Jin S; Sun F; Legro RS; Polotsky AJ; Hansen KR; Coutifaris C; Diamond MP; Eisenberg E; Zhang H; Santoro N;
    Am J Obstet Gynecol; 2017 May; 216(5):493.e1-493.e13. PubMed ID: 28104402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
    Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
    Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.
    Welt CK; Arason G; Gudmundsson JA; Adams J; Palsdóttir H; Gudlaugsdóttir G; Ingadóttir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4361-8. PubMed ID: 16940441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
    Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
    Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.